EORTC protocol 55871

Phase II study of bleomycin, Methotrexate and CCNU in locally advanced, radically inoperable squamous cell carcinoma of the vulva
Trial StatusAll trial activities ended
DatesDate of activation: 15-Jun-87
Closed on : 24-May-94
Data management at EORTCFull
Phase2
Randomized trialNo
TypeAdvanced
Targeted Sample size20
Number of steps1
Drug
Study StaffCostantino Mangioni (Study Coordinator) - Ospedale San Gerardo, Monza
Type of cancerVulvar
Participating GroupsEORTC Gynecological Cancer Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
Back to Protocol section